{"id":"W4386271167","doi":"10.1016/s2152-2650(23)01445-3","title":"MM-371 Pomalidomide, Daratumumab, and Dexamethasone After Lenalidomide Treatment in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): Final Overall Survival (OS) Analysis of the Phase II MM-014 Study","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver General Hospital; Hôpital du Sacré-Cœur de Montréal; Thames Valley Children's Centre; Princess Margaret Cancer Centre; McGill University Health Centre; University of Calgary","funders":"","keywords":"Pomalidomide; Daratumumab; Lenalidomide; Multiple myeloma; Dexamethasone; Medicine; Oncology; Refractory (planetary science); Internal medicine; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002568809,0.001202524,0.002763581,0.000577756,0.00038626,0.00138518,0.001154578,0.0009140121,0.001503511],"category_scores_gemma":[0.001529315,0.0005902739,0.002468323,0.0007743185,0.0006833315,0.001075659,0.0006947797,0.002501433,0.000374891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001581017,"about_ca_system_score_gemma":0.002003645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002225148,"about_ca_topic_score_gemma":0.006384052,"domain_scores_codex":[0.9987175,0.0007092094,0.00007109278,0.0001696737,0.0001369429,0.0001956498],"domain_scores_gemma":[0.9989704,0.0002286916,0.0002803974,0.00007871117,0.00004421255,0.000397577],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7983782,0.008936347,0.1015517,0.0006008858,0.007358911,0.0001879857,0.0001858362,0.003150142,0.006383108,0.0002330973,0.00310387,0.06992988],"study_design_scores_gemma":[0.3758609,0.2497308,0.3520107,0.0001837646,0.008147805,0.0005560548,0.0003248292,0.003399602,0.002508992,0.0006324812,0.006508311,0.0001357541],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994565,0.00351421,0.0000827684,0.0002495409,0.00006980488,0.0001667382,0.000703475,0.00002138629,0.0006269756],"genre_scores_gemma":[0.994679,0.001435618,0.0003098889,0.0004112599,0.0001159114,0.0001861622,0.002155382,0.00001167657,0.0006950639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002763581,"threshold_uncertainty_score":0.01358533,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05760666670056215,"score_gpt":0.3624146327548958,"score_spread":0.3048079660543337,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}